What are the considerations for anticoagulant use in patients experiencing chemotherapy-induced thrombocytopenia, and how can therapy be optimized in this setting?
Gaurav ChauhanContributor
What are the considerations for anticoagulant use in patients undergoing chemotherapy-induced thrombocytopenia?
Share
When managing chemotherapy-induced thrombocytopenia with anticoagulants, balancing bleeding risks and clot prevention is critical. Dose adjustments and regularly monitoring platelet counts are essential.